Objective To study subclinical inflammation in intercritical gout patients and its relation to the
estimated size of monosodium urate crystal deposition and cardiovascular risk factors …

Introduction Baricitinib is an oral Janus kinase (JAK) 1/JAK2 inhibitor approved to treat
rheumatoid arthritis (RA). This study aimed to investigate patients' characteristics …

Gout is the most common type of inflammatory arthritis. Nonsteroidal anti-inflammatory
drugs, corticosteroids, and colchicine are the first-line agents, although they are …

Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in
Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in …

Background Ankylosing spondylitis (AS) is a disease with very characteristic extraarticular
organ involvements. Cardiac conduction disturbances and aortic root diseases are some of …

Background: Patients with autoimmune inflammatory rheumatic diseases (AIIRD) have a
higher burden of infectious diseases compared to the general population. This could be …

Background: Currently, there are no biomarkers to predict respiratory worsening in patients
with Coronavirus infectious disease, 2019 (COVID-19) pneumonia. Objectives: We aimed to …

Background: Gout is the most prevalent inflammatory arthritis. Gout is chronic inflammatory
deposition disease related to an increase of cardiovascular (CV) events and mortality …

Background: Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune
disease of unknown etiology. Tocilizumab (TCZ) is a first-line biological disease-modifying …

Background: Gout is the most common inflammatory arthritis in adults. It is caused by the
chronic deposition of monosodium urate crystals in joints. Hypertension, diabetes mellitus …